PATENT CLAIM ANALYSIS

Application Number: 16016165
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "021900"]

Abstract:
The subject invention provides advantageous new salts of mu-opiate receptor peptides. These salts have been found to have excellent properties in terms of their crystal structure, stability, solubility, lack of impurities and/or the ability to be produced, with these advantageous properties, in amounts sufficient for the production of therapeutic compositions.

Claim (Index 5):
The pharmaceutical composition, according to  claim 4 , wherein the peptide is SEQ ID NO:13.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 94.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14056496', '13265918', '13387051', '13133288', '13508648']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7691041397590659
- 35 USC 102 Novelty (BERT): 0.5760029267609188
- Combined Prediction Score: 0.7497940184592512
- Mean Citation Score: 273.109084
- Max Citation Score: 525.0237
- Similarity Product: 355.16399317570915

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test